Incyte (INCY) PT Raised to $149 at Goldman Sachs
Tweet Send to a Friend
Goldman Sachs raised its price target on Incyte (NASDAQ: INCY) to $149.00 (from $116.00) while maintaining a Buy rating.Analyst Salveen ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
